11.1(top 1%)
impact factor
1.9K(top 10%)
76.2K(top 5%)
124(top 5%)
11.2(top 1%)
extended IF
all documents
doc citations
195(top 5%)

Top Articles

1Functional exhaustion of antiviral lymphocytes in COVID-19 patientsCellular and Molecular Immunology20201,450
2Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccineCellular and Molecular Immunology20201,376
3The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implicationsCellular and Molecular Immunology20201,136
4Molecular mechanisms regulating NLRP3 inflammasome activationCellular and Molecular Immunology2016990
5Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patientsCellular and Molecular Immunology2020799
6Necroptosis, pyroptosis and apoptosis: an intricate game of cell deathCellular and Molecular Immunology2021733
7NADPH oxidases: an overview from structure to innate immunity-associated pathologiesCellular and Molecular Immunology2015725
8Liver immunology and its role in inflammation and homeostasisCellular and Molecular Immunology2016693
9The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseasesCellular and Molecular Immunology2011594
10The cytokine storm of severe influenza and development of immunomodulatory therapyCellular and Molecular Immunology2016571
11Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike proteinCellular and Molecular Immunology2020564
12NK cell-based immunotherapy for malignant diseasesCellular and Molecular Immunology2013518
13NLRP3 inflammasome activation and cell deathCellular and Molecular Immunology2021484
14B cell regulation in cancer and anti-tumor immunityCellular and Molecular Immunology2017427
15Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategiesCellular and Molecular Immunology2016414
16Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodiesCellular and Molecular Immunology2020413
17Tumor-infiltrating lymphocytes in the immunotherapy eraCellular and Molecular Immunology2021403
18The ORF3a protein of SARS-CoV-2 induces apoptosis in cellsCellular and Molecular Immunology2020392
19Immune cells in term and preterm laborCellular and Molecular Immunology2014384
20Serum IgA, IgM, and IgG responses in COVID-19Cellular and Molecular Immunology2020379
21Innate immunity in tuberculosis: host defense vs pathogen evasionCellular and Molecular Immunology2017369
22NF-κB Signaling Pathway, Inflammation and Colorectal CancerCellular and Molecular Immunology2009345
23HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarminsCellular and Molecular Immunology2017333
24When worlds collide: Th17 and Treg cells in cancer and autoimmunityCellular and Molecular Immunology2018331
25Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptorCellular and Molecular Immunology2020331
26Human NK cells: surface receptors, inhibitory checkpoints, and translational applicationsCellular and Molecular Immunology2019327
27CD24: from A to ZCellular and Molecular Immunology2010325
28Tumor-infiltrating B cells: their role and application in anti-tumor immunity in lung cancerCellular and Molecular Immunology2019322
29COVID-19: a new challenge for human beingsCellular and Molecular Immunology2020313
30Current advances in humanized mouse modelsCellular and Molecular Immunology2012303
31An update on the regulatory mechanisms of NLRP3 inflammasome activationCellular and Molecular Immunology2021302
32Hepatocytes: a key cell type for innate immunityCellular and Molecular Immunology2016299
33Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunitiesCellular and Molecular Immunology2021294
34New insights of T cells in the pathogenesis of psoriasisCellular and Molecular Immunology2012290
35NETosis, complement, and coagulation: a triangular relationshipCellular and Molecular Immunology2019284
36SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70Cellular and Molecular Immunology2020280
37Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreactionCellular and Molecular Immunology2018279
38Myeloid immunosuppression and immune checkpoints in the tumor microenvironmentCellular and Molecular Immunology2020273
39Interleukin-17 and its expanding biological functionsCellular and Molecular Immunology2010272
40MicroRNA in TLR signaling and endotoxin toleranceCellular and Molecular Immunology2011272
41A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severityCellular and Molecular Immunology2021270
42IDO1 in cancer: a Gemini of immune checkpointsCellular and Molecular Immunology2018266
43Cell Death Mechanisms Induced by Cytotoxic LymphocytesCellular and Molecular Immunology2009260
44Helper T cell differentiationCellular and Molecular Immunology2019258
45Bone marrow and the control of immunityCellular and Molecular Immunology2012256
46Chemokines and chemokine receptors: their manifold roles in homeostasis and diseaseCellular and Molecular Immunology2004254
47Neutrophil chemoattractant receptors in health and disease: double-edged swordsCellular and Molecular Immunology2020251
48The unique structural and functional features of CXCL12Cellular and Molecular Immunology2018243
49Testicular defense systems: immune privilege and innate immunityCellular and Molecular Immunology2014242
50TLR8: the forgotten relative revindicatedCellular and Molecular Immunology2012234